Halogen-substituted ureas for anion binding: solid state and solution studies

The crystal structure of 1-(4-bromophenyl)-3-cycloheptylurea, C14H19BrN2O

C14H19BrN2O, monoclinic, P21/c (no. 14), a = 12.9782(8) Å, b = 9.1447(6) Å, c = 11.8842(8) Å, β = 98.214(6)°, V = 1395.97(16) Å3, Z = 4, R gt (F) = 0.0637, wR ref (F 2) = 0.1876, T = 293 K.

Urea-Based Ligand as an Efflux Pump Inhibitor: Warhead to Counter Ciprofloxacin Resistance and Inhibit Collagen Adhesion by MRSA

Methicillin-resistant Staphylococcus aureus (MRSA) is a frontline human pathogen in which efflux pump activity confers high levels of antibiotic-resistance and poses a therapeutic challenge in the clinics. The present study illustrates the potential of urea-based ligand as an efflux pump inhibitor (EPI) in order to restore the efficacy of ciprofloxacin (CPX) against MRSA. Among eight structurally varying urea-based ligands, the ligand C8 could significantly inhibit efflux pump activity in the clinical MRSA strain S. aureus 4s and was superior to the known EPI reserpine. In combinatorial treatment, C8 enhanced cellular accumulation of CPX, rendered a 16× decrease in the MIC of CPX, and restored the susceptibility of S. aureus 4s to CPX. Notably, C8 downregulated the expression of norA gene coding for the efflux pump in MRSA and treatment with 10 μM C8 and 2.0 μM CPX prevented emergence of the CPX resistance trait and suppressed MRSA cell growth till 120 generations. For potential anti-MRSA therapy, C8-loaded poly(d,l-lactide-co-glycolide) nanocarrier (C8-PNC) was generated, which facilitated facile release of C8 in physiologically relevant fluid. C8-PNC (loaded with 50 μM C8) rendered efflux pump inhibition and eliminated MRSA in combination with only 2.0 μM CPX. Treatment with the non-toxic C8-PNC (loaded with 50 μM C8) and CPX (2.0 μM) also hindered MRSA adhesion on collagen manifold higher as compared to cells treated with 32 μM CPX and significantly downregulated norA gene expression in non-adhered MRSA cells. The urea-based ligand presented herein is a promising biocompatible therapeutic material for effective mitigation of MRSA infections.

Halogenated isophthalamides and dipicolineamides: the role of the halogen substituents in the anion binding properties

A novel family of amide-based receptors is herein described. Specifically, the role of the halogen substituents at the aryl moieties in the anion binding properties of a series of halogenated isophthalamides and dipicolineamides (L1-L6) was investigated both in solution and in the solid state in order to evaluate the incidence of all possible different and combined weak host-guest interactions. Only L5 and L6 bearing pentafluorophenyl rings as substituents have some affinities for the set of anions studied. In particular, in the case of L5 an interesting behaviour with the formation of a non-symmetric adduct with benzoate and dihydrogen phosphate was hypothesised by ¹H- and ¹⁹F-NMR spectroscopy studies in solution and confirmed by theoretical calculation. The study of the crystal structures of the receptors demonstrated that the steric hindrance determined by the halogen substituents in the receptor molecules influences the accessibility of the anions to the isophthalamide or dipicoline amide NH moieties, thus modulating the affinity for the anion guests.

Straightening out halogen bonds

A new parameter is proposed to quantify the linearity of halogen bonds.

An integrated urea and halogen bond donor based receptor for superior and selective sensing of phosphates

A new RuII based bis-heteroleptic ditopic receptor, 1[PF6]2 (C44H33F12IN10OP2Ru), having integrated anion binding iodotriazole (halogen bond donor) and urea units (-NH bond donor) is employed for selective sensing of phosphates (e.g., H2PO4- and HP2O73-). 1[PF6]2 showed superiority in phosphate sensing in CH3CN as compared to its hydrogen bond donor analogue, 2[PF6]2 (C44H34F12N10OP2Ru), non-urea halogen bond analogue, 3[PF6]2 (C38H27F12IN8P2Ru) and non-urea hydrogen bond donor analogue, 4[PF6]2 (C38H28F12N8P2Ru) in terms of enhanced binding constant values, longer excited state lifetimes and lower detection limit values. 1H-NMR, Isothermal Titration Calorimetry (ITC) and photophysical studies revealed the implementation of the combined role of both the halogen bond donor iodotriazole unit and the -NH unit of the urea moiety for selective and enhanced binding of phosphates.